{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:37:44Z","timestamp":1790696264225,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.clim.2024.110241","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T12:28:48Z","timestamp":1715344128000},"page":"110241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sj\u00f6gren's disease"],"prefix":"10.1016","volume":"264","author":[{"given":"Che\u00efma","family":"Boudjeniba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Soret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Trutschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Baloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Chassagnol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Desvaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Bichat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Aussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moingeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Alarcon-Riquelm\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Fai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Eric","family":"Gottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benno","family":"Schwikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bombardieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel A.G.","family":"van Roon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micka\u00ebl","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Birmele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Laigle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Becht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2024.110241_bb0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren\u2019s syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2024.110241_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.clim.2024.110241_bb0015","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3390\/jcm9072299","article-title":"Current state of knowledge on primary Sj\u00f6gren\u2019s syndrome, an autoimmune exocrinopathy","volume":"9","author":"Parisis","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.clim.2024.110241_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","article-title":"Risk, predictors, and clinical characteristics of lymphoma development in primary Sj\u00f6gren\u2019s syndrome","volume":"41","author":"Solans-Laqu\u00e9","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110241_bb0025","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1093\/rheumatology\/kez052","article-title":"Lymphomas complicating primary Sj\u00f6gren\u2019s syndrome: from autoimmunity to lymphoma","volume":"60","author":"Nocturne","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2024.110241_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67462-z","article-title":"Preva-\u00b4 lence of Sj\u00f6gren\u2019s syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases","volume":"10","author":"Narvaez","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2024.110241_bb0035","doi-asserted-by":"crossref","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","article-title":"The geoepidemiology of Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Mavragani","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2024.110241_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-11-98","article-title":"The prevalence of rheumatic diseases in Central Greece: a population survey","volume":"11","author":"Anagnostopoulos","year":"2010","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.clim.2024.110241_bb0045","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.22115","article-title":"Epidemiology of primary Sj\u00f6gren\u2019s syndrome in a French multiracial\/multiethnic area","volume":"66","author":"Maldini","year":"2014","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2024.110241_bb0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","article-title":"Epidemiology of Sj\u00f6gren syndrome","volume":"20","author":"Beydon","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2017.04.005","article-title":"Sjogren\u2019s syndrome: clinical aspects","volume":"182","author":"Vivino","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110241_bb0060","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and metaanalysis","volume":"74","author":"Qin","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110241_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrrheum.2017.220","article-title":"Moving towards a molecular taxonomy of autoimmune rheumatic diseases","volume":"14","author":"Barturen","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0070","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0075","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/S2665-9913(19)30042-6","article-title":"Symptom-based stratification of patients with primary Sj\u00f6gren\u2019s syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials","volume":"1","author":"Tarn","year":"2019","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23472-7","article-title":"A new molecular classification to drive precision treatment strategies in primary Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Soret","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2024.110241_bb0085","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/art.42265","article-title":"Variability of primary Sj\u00f6gren\u2019s syndrome is driven by interferon-\u03b1 and interferon-\u03b1 blood levels are associated with the class II HLA\u2013DQ locus","volume":"74","author":"Trutschel","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/mco2.69","article-title":"The emerging role of neutrophils in autoimmune-associated disorders: effector, predictor, and therapeutic targets","volume":"2","author":"Fu","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.clim.2024.110241_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","article-title":"Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease","volume":"22","author":"Negrini","year":"2021","journal-title":"Clin. Exp. Med."},{"issue":"Suppl. 126","key":"10.1016\/j.clim.2024.110241_bb0100","first-page":"3","article-title":"One year in review 2020: pathogenesis of primary Sj\u00f6gren\u2019s syndrome","volume":"38","author":"Bombardieri","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0105","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","article-title":"Treatment of primary Sj\u00f6gren syndrome","volume":"12","author":"Saraux","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105406","article-title":"Current and future treatment in primary Sj\u00f6gren\u2019s syndrome \u2013 A still challenging development","volume":"89","author":"Ritter","year":"2022","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clim.2024.110241_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059868","article-title":"Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sj\u00f6gren\u2019s syndrome. Data at enrollment in the prospective ASSESS cohort","volume":"8","author":"Gottenberg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.110241_bb0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/rheumatology\/keq240","article-title":"United Kingdom primary Sjogren\u2019s syndrome registry\u2013a united effort to tackle an orphan rheumatic disease","volume":"50","author":"Ng","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2024.110241_bb0125","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1136\/annrheumdis-2016-210788","article-title":"Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sj\u00f6gren\u2019s syndrome","volume":"76","author":"Tasaki","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110241_bb0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"2024","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"10.1016\/j.clim.2024.110241_bb0135","article-title":"Modifying the false discovery rate procedure based on the information theory under arbitrary correlation structure and its performance in high-dimensional genomic data","volume":"25","author":"Rastaghi","year":"2024","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.clim.2024.110241_bb0140","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.2010.143743","article-title":"EULAR Sj\u00f6gren\u2019s syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sj\u00f6gren\u2019s syndrome","volume":"70","author":"Seror","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110241_bb0145","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sj\u00f6gren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren\u2019s syndrome","volume":"69","author":"Seror","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110241_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143970","article-title":"A transcriptional signature of fatigue derived from patients with primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"James","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.110241_bb0155","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/biostatistics\/kxp059","article-title":"Frozen robust multiarray analysis (fRMA)","volume":"11","author":"McCall","year":"2010","journal-title":"Biostatistics"},{"key":"10.1016\/j.clim.2024.110241_bb0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"10.1016\/j.clim.2024.110241_bb0165","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","article-title":"lumi: a pipeline for processing Illumina microarray","volume":"24","author":"Du","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clim.2024.110241_bb0170","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2006","journal-title":"Biostatistics"},{"key":"10.1016\/j.clim.2024.110241_bb0175","first-page":"10","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EM-Bnet.journal"},{"key":"10.1016\/j.clim.2024.110241_bb0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clim.2024.110241_bb0185","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nmeth.2810","article-title":"Similarity network fusion for aggregating data types on a genomic scale","volume":"11","author":"Wang","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.clim.2024.110241_bb0190","doi-asserted-by":"crossref","first-page":"P10008","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","article-title":"Fast unfolding of communities in large networks","volume":"2008","author":"Blondel","year":"2008","journal-title":"J. Stat. Mech."},{"key":"10.1016\/j.clim.2024.110241_bb0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2024.110241_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24584-w","article-title":"Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data","volume":"12","author":"Altman","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2024.110241_bb0205","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.clim.2024.110241_bb0210","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S2665-9913(20)30057-6","article-title":"Leflunomide\u2013hydroxychloroquine combination therapy in patients with primary Sj\u00f6gren\u2019s syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial","volume":"2","author":"Van der Heijden","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0215","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/annrheumdis-2021-222054","article-title":"Development and preliminary validation of the Sj\u00f6gren\u2019s tool for assessing response (STAR): a consensual composite score for assessing treatment effect in primary Sj\u00f6gren\u2019s syndrome","volume":"81","author":"Seror","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110241_bb0220","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.4049\/jimmunol.169.7.3947","article-title":"NF-\u03baB regulation in human neutrophils by nuclear I\u03baB\u03b1: correlation to apoptosis","volume":"169","author":"Castro-Alcaraz","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110241_bb0225","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.clim.2024.110241_bb0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary Sj\u00f6gren syndrome with rituximab","volume":"160","author":"Devauchelle-Pensec","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clim.2024.110241_bb0235","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.40093","article-title":"Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sj\u00f6gren\u2019s syndrome","volume":"69","author":"Bowman","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0240","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/107999099313497","article-title":"Treatment of primary Sjogren\u2019s syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: A phase II clinical trial","volume":"19","author":"Ship","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.clim.2024.110241_bb0245","first-page":"96","article-title":"Etanercept in the treatment of patients with primary Sj\u00f6gren\u2019s syndrome: a pilot study","volume":"31","author":"Zandbelt","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0250","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00262-018-2150-z","article-title":"Quantifying tumor-infiltrating immune cells from transcriptomics data","volume":"67","author":"Finotello","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clim.2024.110241_bb0255","doi-asserted-by":"crossref","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology","volume":"35","author":"Sturm","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clim.2024.110241_bb0260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/biom11020251","article-title":"The role of interferons in the pathogenesis of Sj\u00f6gren\u2019s syndrome and future therapeutic perspectives","volume":"11","author":"Papa","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.clim.2024.110241_bb0265","doi-asserted-by":"crossref","first-page":"99","DOI":"10.31138\/mjr.33.1.99","article-title":"Clinical phenotype and mechanisms of leukopenia\/neutropenia in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"33","author":"Stergiou","year":"2022","journal-title":"Mediterr. J. Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0270","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s10067-015-3081-0","article-title":"Clinical and serologic features of primary Sj\u00f6gren\u2019s syndrome concomitant with autoimmune hemolytic anemia: a large-scale cross-sectional study","volume":"34","author":"Wen","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2024.110241_bb0275","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/ard.59.11.841","article-title":"Leflunomide: mode of action in the treatment of rheumatoid arthritis","volume":"59","author":"Breedveld","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110241_bb0280","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3949\/ccjm.85a.17034","article-title":"Hydroxychloroquine: an old drug with new relevance","volume":"85","author":"Shippey","year":"2018","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.clim.2024.110241_bb0285","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","article-title":"Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines","volume":"186","author":"Ku\u02c7znik","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110241_bb0290","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","article-title":"14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends","volume":"13","author":"Erkan","year":"2014","journal-title":"Autoimmun. Rev."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624003504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624003504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T20:21:33Z","timestamp":1738441293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624003504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":58,"alternative-id":["S1521661624003504"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.110241","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.07.05.23292036","asserted-by":"object"}]},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sj\u00f6gren's disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.110241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110241"}}